3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
243
Stomach Neoplasms
23
Breast Neoplasms, Male
16
Neoplasm Metastasis
14
Neoplasms
8
Inflammatory Breast Neoplasms
8
Esophageal Neoplasms
8
Brain Neoplasms
8
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
4
Urologic Neoplasms
3
Triple Negative Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Ductal, Breast
3
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Lobular
2
Carcinoma, Intraductal, Noninfiltrating
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Solid Cancers
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Patient Preference
1
Patient Compliance
1
Interventions
Everolimus
4
Temozolomide
3
Octreotide
2
Capecitabine
2
Bevacizumab
2
temsirolimus
1
regorafenib
1
pazopanib
1
motesanib diphosphate
1
folfirinox
1
cixutumumab
1
batifiban
1
Sunitinib
1
Sorafenib
1
Sirolimus
1
Oxaliplatin
1
Leucovorin
1
Granulocyte Colony-Stimulating Factor
1
Fluorouracil
1
Filgrastim
1
Fentanyl
1
Doxorubicin
1
Cytokines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Islet Cell
×
Trastuzumab
×
Clear all
No trials found.